Biontech has been a great steady performer all year. recently, they partnered with Pfizer to make a new vaccine what is being implemented in UK.
My concern for this is now, they have shown their cards. The vaccine has been in the news for nearly 2 months. Have those gains been realized already I ask myself.
I may look else where for more solid ideas, or may take a very modest position if BIONTECH trends on the base line of this trend, showing some divergence.
My concern for this is now, they have shown their cards. The vaccine has been in the news for nearly 2 months. Have those gains been realized already I ask myself.
I may look else where for more solid ideas, or may take a very modest position if BIONTECH trends on the base line of this trend, showing some divergence.
Komen:
I'll be a buyer at $82
Komen:
So, it's at $81.95. Looking at options 2 months out. Would like to see a form of capitulation before moving in though
Komen:
Not the perfect set up, but ok